Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.

[1]  Christian Gluud,et al.  Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. , 2007, JAMA.

[2]  G. Greisen,et al.  Agreement between Cochrane Neonatal Group reviews and clinical guidelines for newborns at a Copenhagen University Hospital—a cross‐sectional study , 2007, Acta paediatrica.

[3]  P. L. Petersen,et al.  Effect of perioperative β blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial , 2006, BMJ : British Medical Journal.

[4]  L. Poston,et al.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial , 2006, The Lancet.

[5]  Gordon H Guyatt,et al.  Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.

[6]  J. Ioannidis.  Why Most Published Research Findings Are False , 2005, PLoS medicine.

[7]  J. Ioannidis.  Contradicted and initially stronger effects in highly cited clinical research. , 2005, JAMA.

[8]  Gordon H Guyatt,et al.  How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.

[9]  Patrick J. Kelly,et al.  A Practical Comparison of Group-Sequential and Adaptive Designs , 2005, Journal of biopharmaceutical statistics.

[10]  V. Fedorov,et al.  The design of multicentre trials , 2005, Statistical methods in medical research.

[11]  D. Altman,et al.  Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors , 2005, BMJ : British Medical Journal.

[12]  Rachel Churchill,et al.  Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. , 2004, Journal of clinical epidemiology.

[13]  C. Gluud,et al.  Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis , 2004, The Lancet.

[14]  Sanjay Kaul,et al.  Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. , 2004, Journal of the American College of Cardiology.

[15]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[16]  E. Bell,et al.  Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. , 2003, The Cochrane database of systematic reviews.

[17]  Kay Dickersin,et al.  Registering clinical trials. , 2003, JAMA.

[18]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[19]  David J Spiegelhalter,et al.  Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. , 2002, International journal of epidemiology.

[20]  Douglas G Altman,et al.  Meta-analysis, Simpson's paradox, and the number needed to treat , 2002, BMC medical research methodology.

[21]  K. Abrams,et al.  The importance of effect mechanism in the design and interpretation of clinical trials: the role of magnesium in acute myocardial infarction. , 2002, Progress in cardiovascular diseases.

[22]  K. Barrington,et al.  Nitric oxide for respiratory failure in infants born at or near term. , 2017, The Cochrane database of systematic reviews.

[23]  Douglas G. Altman,et al.  Systematic reviews in health care : meta-analysis in context , 2008 .

[24]  A. Ohlsson,et al.  Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. , 2004, The Cochrane database of systematic reviews.

[25]  Christian Gluud,et al.  Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses , 2001, Annals of Internal Medicine.

[26]  D. Tudehope,et al.  Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. , 2001, The Cochrane database of systematic reviews.

[27]  D L DeMets,et al.  Computations for group sequential boundaries using the Lan-DeMets spending function method. , 2000, Controlled clinical trials.

[28]  K. Barrington.  Umbilical artery catheters in the newborn: effects of position of the catheter tip. , 1999, The Cochrane database of systematic reviews.

[29]  J. Ioannidis,et al.  Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. , 1999, Journal of clinical epidemiology.

[30]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[31]  Jonathan AC Sterne,et al.  Meta-analysis: is moving the goal post the answer? , 1998, The Lancet.

[32]  S. Yusuf,et al.  Overcoming the limitations of current meta-analysis of randomised controlled trials , 1998, The Lancet.

[33]  S. Yusuf,et al.  Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. , 1997, Controlled clinical trials.

[34]  S. Yusuf,et al.  Strengths and limitations of meta-analysis: larger studies may be more reliable. , 1997, Controlled clinical trials.

[35]  E. Özek,et al.  Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants , 1997 .

[36]  C S Berkey,et al.  Uncertainty of the time of first significance in random effects cumulative meta-analysis. , 1996, Controlled clinical trials.

[37]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[38]  S. Goodman,et al.  The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.

[39]  K. K. Lan,et al.  Discrete sequential boundaries for clinical trials , 1983 .

[40]  S. Pocock.  Group sequential methods in the design and analysis of clinical trials , 1977 .

[41]  P Armitage.  Sequential analysis in therapeutic trials. , 1969, Annual review of medicine.